Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Ouderschapseducatieprogramma II (TP2)

Het gebruik van slimme luidsprekertechnologie om opvoedingsondersteuning te bieden aan ouders van jonge kinderen

The goal of this clinical trial is to learn whether Talk Parenting, a voice-based program delivered through an Amazon Echo Dot (Alexa), can help parents and caregivers of children ages 3-5 years improve challenging bedtime and morning routines. The main questions it aims to answer are:

Does using Talk Parenting improve families' bedtime and morning experiences and children's sleep/wake habits?

Does using Talk Parenting improve parents' routine-related parenting practices and confidence, strengthen the parent-child relationship, and reduce children's behavior problems and parents' stress?

Researchers will compare families who receive Talk Parenting right away to families who wait 6 weeks to receive the program (a waitlist control group receiving usual services during the wait).

Participants will:

Complete online questionnaires at the start of the study and again about 6 weeks later (and a follow-up questionnaire later in the study).

Receive a pre-configured Amazon Echo Dot (to keep) and instructions to use Talk Parenting routines at home, including a bedtime routine, a brief calming routine, and a morning routine (enabled after the first 2 weeks).

Studie Overzicht

Gedetailleerde beschrijving

I. Study overview and rationale.

This study is a two-arm randomized controlled trial designed to evaluate the efficacy, acceptability, and usability of Talk Parenting, a voice-delivered (Alexa-enabled) parenting support program intended to improve families' bedtime and morning routines for children ages 3-5 years. The trial will evaluate whether access to Talk Parenting leads to improvements in routine functioning (bedtime and morning experience), children's sleep/wake habits, parents' engagement in targeted parenting practices, parents' self-efficacy for handling routines and challenging child behavior, and the parent-child relationship, as well as reductions in children's behavior problems and parents' stress.

II. Design.

A total of 184 families (primary parent/caregiver and one child age 3-5 years who presents the most bedtime/morning challenges) will be enrolled and randomized after completing the baseline assessment (T1) to either:

Immediate Talk Parenting (Tx): receive Talk Parenting immediately, or

Waitlist Control (WC): wait 6 weeks to receive Talk Parenting while continuing to receive "care as usual" services through their parenting support agency.

All participating families will be re-assessed (T2) 6 weeks after their baseline T1 assessment. At 6 weeks after T2, the WC group will complete their T3 assessment, and at 3 months after T2, the Tx condition will complete their T3 assessment.

This design supports (1) a between-group efficacy test at 6 weeks post-baseline (Tx vs WC at T2), (2) a test of maintenance of gains in the Tx group from T2 to T3 (approximately 3 months after T2), and (3) an initial replication check of within-subject effects in the WC group after they receive the intervention (T2 to T3).

III. Setting, recruitment, and population.

Families will be recruited through community and early childhood service organizations in Oregon, including Head Start sites, Early Childhood Hubs, Parenting Now, WIC and Healthy Start in Lane County, and other similar parenting agencies. Participating families are expected to have risk factors that qualify them for services at these agencies (e.g., low income, family stress), and children may be at elevated risk for psychosocial/behavioral problems and/or poor school readiness. The study will over-enroll to account for anticipated attrition (planned ~30% attrition at T2 and ~40% at T3; target N at T2 is 128, 64 per group).

IV. Intervention delivery and implementation.

Families randomized to Tx will be provided a pre-configured Amazon Echo Dot and associated hardware, along with instructions to set up and initiate Talk Parenting. Talk Parenting will be enabled in a staged manner to support implementation:

At initiation: Bedtime Routine and Calming Down Mini-Routine enabled

After 2 weeks: Morning Routine enabled

Tx families will have access to Bedtime/Calming routines for 6 weeks and Morning routine for 4 weeks prior to the 6-week assessment (T2). After WC families complete their 6-week assessment (T2), they will receive Talk Parenting using the same staged enablement process. Families keep the Echo Dot after participation.

V. Study procedures and assessment schedule.

Parents will complete questionnaires via the Qualtrics online platform at:

T1 (baseline): prior to randomization

T2 (6 weeks after T1): both Tx and WC

T3 (follow-up):

Tx: ~3 months after T2

WC: ~6 weeks after T2 (after receiving Talk Parenting)

VI. Data sources and measurement domains (high level).

Key domains assessed across T1/T2/T3 include:

Parenting practices targeted to bedtime and morning routines

Parenting self-efficacy related to routines and challenging child behaviors

Parent stress

Child sleep problems/behaviors

Child behavioral and emotional adjustment

Parent-child relationship quality

For intervention engagement, Talk Parenting usage will be captured using objective usage metrics from the Alexa back-end database. Satisfaction, acceptability, usability, and problems/difficulties will be assessed at the post-intervention timepoint for each condition (T2 for Tx; T3 for WC). Demographics are collected at baseline (T1).

VII. Feasibility and adoption (implementation-oriented outcomes).

Commercial/implementation feasibility will be assessed via an advisory board and recruitment partners using a practitioner-focused satisfaction/acceptability measure to characterize acceptability for target families, feasibility for parenting education agencies, and interest in adopting Talk Parenting.

Studietype

Ingrijpend

Inschrijving (Geschat)

184

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

    • Oregon
      • Springfield, Oregon, Verenigde Staten, 97477-2019
        • Oregon Research Behavioral Intervention Strategies, Inc.
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

3 jaar tot 90 jaar (Kind, Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Referred by a participating agency
  • Child 3-5 years old who lives with the parent at least half time
  • The primary parent in the home (typically the mother but not always)
  • Speaks English
  • Has access to a computer, tablet, or mobile phone at home
  • Access to high-speed internet at home is desired but not required.

The project will cover internet costs for a small number of participants if needed. The participating agencies all serve families who are low-income and/or experiencing economic hardship, stressful family relationships, children's behavior problems, or household instability; thus referred families will be experiencing one or more of these risk factors for an at-risk family environment.

Exclusion Criteria:

  • Families of target-age children with a developmental disability severe enough that the child cannot speak or follow simple directions will be excluded
  • Families of target-age children whose needs are beyond the scope of Talk Parenting will be excluded

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Talk Parenting Program

In a 6-week session, families will use at home the Talk Parenting program, a smart speaker app designed to provide parents with in situ experiential support for building positive family bedtime and morning routines. The Bedtime Routine, Morning Routine, and Calming Down Mini-Routine modules of Talk Parenting will guide families in creating healthy bedtime and morning routines to foster healthy sleep/wake habits, provide experiential practice in self-regulation skills, and promote a positive parent-child relationship.

In a 6-week session, families will use at home the Talk Parenting program, a smart speaker app designed to provide parents with in-situ experiential support for building positive family bedtime and morning routines. The Bedtime Routine, Morning Routine, and Calming Down Mini-Routine modules of Talk Parenting will guide families in creating healthy bedtime and morning routines to foster healthy sleep/wake habits, provide experiential practice in self-regulation skills, and promote a positive parent-child relationship.

Ander: Waitlist Control

Families will receive access to the intervention after the T2 assessment (6 weeks after the baseline T1 assessment).

In a 6-week session, families will use at home the Talk Parenting program, a smart speaker app designed to provide parents with in-situ experiential support for building positive family bedtime and morning routines. The Bedtime Routine, Morning Routine, and Calming Down Mini-Routine modules of Talk Parenting will guide families in creating healthy bedtime and morning routines to foster healthy sleep/wake habits, provide experiential practice in self-regulation skills, and promote a positive parent-child relationship.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Short-Form Children's Sleep Habits Questionnaire (SF-CSHQ)
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

Children's bedtime/sleep problems will be measured with the Short-Form Children's Sleep Habits Questionnaire (SF-CSHQ), a 23-item version of the widely used CSHQ. Respondents answer on a 5-point scale (1=never; 5=always-7x/week); a mean score will be computed and can range from 1 to 5, with higher scores indicating worse outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Child Adjustment & Parent Self-Efficacy Scale (CAPES) : Behavioral Problems Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Child Adjustment and Parent Efficacy Scale (CAPES) measures children's behaviors and emotional adjustment. The Behavior Problems subscale consists of 16 problematic and 8 reverse-coded positive behaviors. Respondents answer on a 4-point scale (0=Not at all; 3=Very much); the summed scores range from 0 to 72, with higher scores indicating worse outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Child Adjustment & Parent Self-Efficacy Scale (CAPES) : Emotional Maladjustment Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Child Adjustment and Parent Efficacy Scale (CAPES) measures children's behaviors and emotional adjustment. The Emotional Maladjustment subscale has 3 items. Respondents answer on a 4-point scale (0=Not at all; 3=Very much); the summed scores range from 0 to 9, with higher scores indicating worse outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Child Adjustment & Parent Self-Efficacy Scale (CAPES) : Parent Self-Efficacy Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Child Adjustment and Parent Efficacy Scale (CAPES) measures children's behaviors and emotional adjustment. The CAPES is also used to measure parents' self-efficacy; parents rate their confidence that they can successfully deal with each of the 19 negative behaviors/emotions on the CAPES. Respondents answer on a 10-point scale (1=Certain I can't do it; 10=Certain I can do it); the summed scores range from 19-190, with higher scores indicating better outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Self-Efficacy for Parenting Tasks Index - Toddler Scale (SEPTI-TS): Discipline Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Self-Efficacy for Parenting Tasks Index - Toddler Scale - Short Form (SEPTI-TS-SF) is used to measure parents' self-efficacy for discipline- and routines-related parenting tasks. The Discipline subscale is measured with 6 items. Respondents answer on a 6-point scale (1=Disagree strongly; 6=Agree strongly); average scores range from 1 to 6, with higher scores indicating better outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Self-Efficacy for Parenting Tasks Index - Toddler Scale (SEPTI-TS): Routines Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Self-Efficacy for Parenting Tasks Index - Toddler Scale - Short Form (SEPTI-TS-SF) is used to measure parents' self-efficacy for a discipline- and routines-related parenting tasks. The Routines subscales are measured with 6 items each. Respondents answer on a 6-point scale (1=Disagree strongly; 6=Agree strongly); average scores range from 1 to 6, with higher scores indicating better outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Engagement in Program-Targeted Parenting Practices (PTPP) - Parent's Self Efficacy Scale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

Parents' self-efficacy for engaging in the parenting practices targeted by the intervention is measured via the Engagement in Target Activities with Child measure, Parents' Self-Efficacy subscale. Created for this study, these number of items will be determined and will items ask parents to rate how confident they are that they know how to do a series of parenting practices targeted by the program, on a scale of 1 to 10 (1 = Not at all confident; 10 = Highly confident). Average scores range from 1 to 10, with higher scores indicating greater parental self-efficacy (better outcome).

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Engagement in Program-Targeted Parenting Practices (PTPP) - Frequency Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The frequency of parents' engagement in the parenting practices targeted by the intervention is measured via the Engagement in Target Activities with Child measure, Frequency subscale. Created for this study, the number of items will be determined and will ask parents to report the frequency with which they have engaged in target parenting practices in the past 4 weeks. Parents report their frequency on a 6-point scale (0 = "Never in the past month" to 5 = "Every day in past month:). Averaged scores range from 0 to 5, with higher scores indicating more frequent parental engagement in the target activities (better outcome).

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Parental Stress Scale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Parental Stress Scale (PSS) is comprised of 18 items that ask about positive (emotional benefits, personal development) and negative (demands on resources, restrictions) themes of parenthood. Respondents answer on a 5-point Likert "Strongly disagree" to "Strongly agree" scale in terms of their typical relationship with their child. An overall sum score is derived and can range from 18 to 90, with higher scores indicating worse outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Child-Parent Relationship Scale - Short Form: Conflicts Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Child-Parent Relationship Scale - Short Form (CPRS-SF) is comprised of 14 parent-report items that ask the parent for their assessment of the child-parent relationship, the child's emotional stance toward the parent, and the parent's feelings toward the child.Two subscales are derived: Conflicts and Positive Aspects/Closeness. The Conflicts subscale is measured by 7 items on a 5-point scale (1=Definitely does not apply; 5=Definitely applies); average scores range from 1 to 5, with higher scores indicating worse outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)
Child-Parent Relationship Scale - Short Form: Positive Aspects/Closeness Subscale
Tijdsspanne: T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

The Child-Parent Relationship Scale - Short Form (CPRS-SF) is comprised of 14 parent-report items that ask the parent for their assessment of the child-parent relationship, the child's emotional stance toward the parent, and the parent's feelings toward the child.Two subscales are derived: Conflicts and Positive Aspects/Closeness. The Closeness subscale is measured with 7 items on a 5-point scale (1 = Defintely does not apply; 5 = Defintely apply); average scores range from 1 to 5, with higher scores indicating better outcomes.

T1 (baseline), T2 (6 weeks after T1), T3 (3 months after T2 for Experimental, 6 weeks after T2 for Waitlist)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: David R Smith, PhD, Oregon Research Behavioral Intervention Strategies, Inc.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 november 2026

Primaire voltooiing (Geschat)

1 maart 2028

Studie voltooiing (Geschat)

1 april 2028

Studieregistratiedata

Eerst ingediend

3 maart 2026

Eerst ingediend dat voldeed aan de QC-criteria

6 maart 2026

Eerst geplaatst (Werkelijk)

10 maart 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

5 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

30 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • HD101190-02
  • 2R44HD101190-02 (Subsidie/contract van de Amerikaanse NIH)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren